ArticleVaccines2024

The Protective Efficacy of a SARS-CoV-2 Vaccine Candidate B.1.351V against Several Variant Challenges in K18-hACE2 Mice.

Jie Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.